This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hiatt, W. R. Articles by Nies, A. S. Search for Related Content PubMed PubMed Citation Articles by Hiatt, W. R. Articles by Nies, A. S.

Circulation, Vol 72, 1226-1231, Copyright © 1985 by American Heart Association

ARTICLES

Effect of beta-adrenergic blockers on the peripheral circulation in patients with peripheral vascular disease

WR Hiatt, S Stoll and AS Nies

Beta-Adrenergic blockers have not been widely used in patients with peripheral vascular disease because these drugs have been reported to worsen the symptoms of intermittent claudication. To test this assumption we studied the effects of a beta 1-selective and a nonselective beta-adrenergic blocker on postexercise calf blood flow and symptoms of claudication in 19 patients with mild-to-moderate peripheral vascular disease. Subjects received placebo for 3 weeks, and then were randomized to 120 mg/day propranolol or 150 mg/day metoprolol with the use of a crossover design. Blood flow in the calf was measured by strain-gauge plethysmography at rest and immediately after exercise on a bicycle ergometer at a low and a high workload. The symptoms of claudication were monitored during bicycle exercise and by patient diaries maintained between visits. Maximal exercise heart rate was reduced an equivalent amount by metoprolol (19 beats/min) and propranolol (16 beats/min). Mean arterial pressure was reduced by propranolol at rest and by both drugs with exercise. Calf blood flow was not affected by either drug compared with placebo at rest or at either workload. In addition, the symptoms of claudication were not worsened by either drug. We conclude that despite evidence of beta 1- adrenergic blockade and a lowering of arterial pressure, neither beta- adrenergic blocker adversely affected the peripheral circulation.

This article has been cited by other articles:

				C. R. Narins, W. Zareba, A. J. Moss, V. J. Marder, P. M. Ridker, R. J. Krone, and E. Lichstein Relationship Between Intermittent Claudication, Inflammation, Thrombosis, and Recurrent Cardiac Events Among Survivors of Myocardial Infarction Arch Intern Med, February 23, 2004; 164(4): 440 - 446. [Abstract] [Full Text] [PDF]

				W. R. Hiatt Medical Treatment of Peripheral Arterial Disease and Claudication N. Engl. J. Med., May 24, 2001; 344(21): 1608 - 1621. [Full Text] [PDF]

				U. Thadani and T. L. Whitsett {beta}-Adrenergic Blockers and Intermittent Claudication: Time for Reappraisal Arch Intern Med, September 1, 1991; 151(9): 1705 - 1707. [Abstract] [PDF]

				K. Radack and C. Deck {beta}-Adrenergic Blocker Therapy Does Not Worsen Intermittent Claudication in Subjects With Peripheral Arterial Disease: A Meta-analysis of Randomized Controlled Trials Arch Intern Med, September 1, 1991; 151(9): 1769 - 1776. [Abstract] [PDF]

				J. P Cooke and M. A Creager Management of the patient with intermittent claudication Vascular Medicine, March 1, 1991; 2(1): 19 - 31. [PDF]

				W. R Hiatt, E. E Wolfel, and J. G Regensteiner Exercise in the treatment of intermittent claudication due to peripheral arterial disease Vascular Medicine, March 1, 1991; 2(1): 61 - 70. [PDF]